Background Enterovirus D68 was implicated in a widespread outbreak of severe respiratory illness across the USA in 2014 and has also been reported sporadically in patients with acute fl accid myelitis. We aimed to investigate the association between enterovirus D68 infection and acute fl accid myelitis during the 2014 enterovirus D68 respiratory outbreak in the USA.
Introduction
Enteroviruses cause a broad spectrum of clinical illnesses, including acute respiratory infection, febrile rash, handfoot-and-mouth disease, meningitis, encephalitis, and, rarely, acute fl accid paralysis. Enterovirus D68, which was fi rst identifi ed in 1962, causes respiratory illness, 1 but has also been sporadically detected in patients with acute fl accid paralysis. [2] [3] [4] [5] [6] [7] In 2014, in the USA, a nationwide outbreak of enterovirus D68 occurred in association with severe respiratory illness, 8 with more than 1150 confi rmed cases. This enterovirus D68 outbreak coincided with an apparent increase in incidence of reported cases of acute fl accid paralysis, including a temporally associated cluster in Colorado. 2, 7 To more specifi cally describe this syndrome, the Centers for Disease Control and Prevention and the California Department of Public Health (CDPH) have proposed the term acute fl accid myelitis to include the subset of acute fl accid paralysis cases with myelitis primarily involving the grey matter. 9 However, whether enterovirus D68 is an incidental fi nding in these patients or a newly emerging cause of acute fl accid myelitis remains uncertain.
Metagenomic next-generation sequencing (NGS) is a promising approach for the detection and discovery of pathogens in diseases that remain challenging to diagnose, such as encephalitis, [10] [11] [12] and for investigation of outbreaks. 13, 14 Herein, we combined pathogen identifi cation by metagenomic NGS, viral genome recovery, and enterovirus D68 phylogenetic analysis to investigate cases of acute fl accid myelitis in California and Colorado from 2012 to 2014, most of which occurred during the height of the 2014 enterovirus D68 respiratory outbreak in the USA.
Methods

Study design and patients
Patients with acute fl accid myelitis who presented to Children's Hospital Colorado (CHCO; Aurora, CA, USA) or Children's Hospital Los Angeles (CHLA; Los Angeles, CA, USA) from Nov 24, 2013 , to Oct 11, 2014 , or who were identifi ed via statewide surveillance by the CDPH from Jan 1, 2012, to Oct 4, 2014 , were included in the study. All study patients met the clinical case defi nition of acute fl accid myelitis, and there were no age limits or other inclusion criteria. Acute fl accid myelitis cases were defi ned as patients with acute fl accid weakness; with radiological (MRI) or neurophysiological (electro myogram [EMG] ) evidence of acute spinal motor neuron injury; and who did not meet criteria for Guillain-Barré syndrome, West Nile virus infection, stroke, transverse myelitis, myasthenia gravis, botulism, or other known causes of acute fl accid paralysis. 9 The clinical features of these patients have been summarised previously. 2, 5, 7 Local institutional review board approval was obtained from CHCO and CHLA for collection of clinical samples and medical chart review, and from University of California, San Francisco (UCSF; San Francisco, CA, USA) for genomic and metagenomic analyses for masked patient samples. Patients or their surrogates (eg, parents on behalf of their children) provided written informed consent for enrol ment in the study. Institutional review board approval was not required for samples from the CDPH because they were collected and analysed under a statewide mandate for the purpose of public health surveillance.
Procedures
Nasopharyngeal swab or wash, oropharyngeal swab or wash, serum, whole blood, rectal swab, stool, and cerebrospinal fl uid (CSF) samples from patients were taken at various timepoints during hospital admission and were analysed by PCR or metagenomic NGS, or both (appendix A).
Clinical samples that had already undergone routine laboratory testing at CDPH, CHCO, and CHLA were screened for enterovirus D68 using a pan-rhinovirus and enterovirus RT-PCR targeting the 5ʹ-untranslated region (5ʹ-UTR), 15 followed by heminested PCR to increase sensitivity (appendix A). Samples positive for enterovirus D68 were further screened using a VP1 heminested RT-PCR assay developed at UCSF (appendix A) and a 5ʹ-UTR SYBR Green quantitative RT-PCR assay 16 to obtain viral copy numbers by standard curve analysis.
Metagenomic NGS for pathogen detection is shotgun (ie, random) sequencing of the genomic nucleic acid
Research in context
Evidence before this study A nationwide outbreak of enterovirus D68 associated with severe cases of respiratory illness occurred in 2014. In addition to respiratory symptoms, a few patients infected with enterovirus D68, nearly all of whom were children, presented with acute fl accid myelitis. However, evidence addressing whether enterovirus D68 is an incidental fi nding in these patients or a newly emerging cause of acute fl accid myelitis is limited. Also, several studies have reported detection of enterovirus D68 in individuals with acute fl accid myelitis or in patients with respiratory illnesses, but genomic and metagenomic analyses of enterovirus D68 from clusters of patients presenting with acute fl accid myelitis have not been described.
Added value of this study
In this study, we report new and extensive genomic data that strengthen the association between enterovirus D68 infection and acute fl accid paralysis. A novel B1 strain of enterovirus D68 was detected in two temporally and geographically linked clusters of acute fl accid myelitis that occurred during the height of the 2014 respiratory outbreak, and was also detected for the fi rst time in blood from a child with acute fl accid myelitis during the progressive phase of his paralytic illness. Although enterovirus D68 was not detected in cerebrospinal fl uid from patients with acute fl accid myelitis, no other candidate infectious cause was identifi ed in cerebrospinal fl uid by metagenomic deep sequencing.
Implications of all the available evidence
The collective evidence provided in this study implicates the virus as a trigger of acute fl accid myelitis, and the identifi cation of enterovirus D68 viraemia shows its capacity to cause systemic infection. Thus, this study underscores the importance of ongoing clinical and public health surveillance for enterovirus D68 and the need for an eff ective treatment or vaccine for enterovirus-D68-associated illness. The fi nding of one child with acute fl accid myelitis and her sibling with only upper respiratory illness shows that the clinical manifestations of enterovirus D68 infection can be variable and suggests a potential role for host-specifi c factors, such as diff erential immunological responses, in the pathogenesis of enterovirus D68. Although no one enterovirus D68 polymorphism was specifi c to patients with acute fl accid myelitis, the identifi ed sequence homologies at several aminoacid sites with neuropathogenic enteroviruses merits further investigation.
See Online for appendix A (RNA and DNA) of a clinical sample, followed by microbial identifi cation by comparison with comprehensive reference databases such as the National Institutes of Health GenBank. 17 We did pathogen identifi cation from metagenomic NGS data using the SURPI computational pipeline (appendix A). 18 Full VP1 sequences were obtained using an entero virus-D68-specifi c heminested RT-PCR assay targeting the VP1 region (appendix A), followed by Sanger sequencing. Consensus genomes were recovered by mapping reads and de novo assembled contigs (ie, contiguous sequences) obtained by metagenomic NGS (with or without viral probe enrichment) or Sanger sequencing to the reference enterovirus D68 Fermon strain (AF081348). We did phylogenetic and mo lecu lar clock analyses by alignment of recovered entero virus D68 VP1 or complete genome sequences with all corresponding available sequences in GenBank. Full details, including accession numbers for the genomic and metagenomic sequencing data, are given in appendix A.
Statistical analysis
p values comparing patients with enterovirus-D68-positive and enterovirus-D68-negative acute fl accid myelitis were calculated using the two-tailed Fisher's exact test for categorical variables, two-sample unpaired t test for means, and Mann-Whitney U test for medians.
Role of the funding source
The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had fi nal responsibility for the decision to submit for publication.
Results
48 patients were included: 25 with acute fl accid myelitis, two with enterovirus-associated encephalitis, fi ve with enterovirus-D68-associated upper respiratory illness (URI), and 16 consecutive paediatric patients with aseptic meningitis or encephalitis who tested positive at CHLA for enterovirus between August and October, 2014, and were subsequently screened for enterovirus D68 (fi gure 1). Among the 25 patients with acute fl accid myelitis, 16 originated from California and nine from Colorado. In California, formal statewide surveillance for cases of acute fl accid myelitis was initiated by the CDPH in June, 2012. As of October, 2014, 37 patients with acute fl accid myelitis had been tested at the CDPH, one before (in January, 2012, with hospital admission beginning in December, 2011) and 36 during the surveillance period. At the CHCO, 16 paediatric patients admitted to hospital met the case defi nition of acute fl accid myelitis from January, 2012, to October, 2014. Three of the patients from California were part of a geographically and temporally linked cluster at CHLA from August to October, 2014. From Colorado, we analysed samples collected from eight of ten patients with acute fl accid myelitis corresponding to a previously reported cluster in August to October, 2014, at CHCO (consent was not available for the remaining two patients), 2, 7 and one additional patient diagnosed in November, 2013. Thus, 11 of 25 patients with acute fl accid myelitis who were analysed in this study comprised part of a cluster, whereas the remaining 14 cases were sporadic.
All 25 cases of acute fl accid paralysis included in this study met the case defi nition for diagnosis of acute fl accid myelitis and presented with acute fl accid weakness, anterior horn cell grey matter involvement on MRI or EMG, and no identifi ed cause (table 1) . Patients with acute fl accid myelitis were predominantly children, with a median age of 7·0 years (range 0·3-73·0) and 60% were male. 20 (80%) of 25 patients reported URI prodrome, a mean of 5·6 days (SD 3·2) before the appearance of acute fl accid myelitis symptoms, 8·0 days (3·7) before CSF collection, and 11·6 days (7·2) before naso pharyngeal and oro pharyngeal collection. Patients with acute fl accid myelitis with or without enterovirus D68 were largely comparable, with the exceptions of fewer days between URI onset and nasopharyngeal and oropharyngeal collection (7·8 vs 15·1 days; p=0·012) and decreased likelihood of corticosteroid treatment after onset of acute fl accid myelitis (33% vs 77%; p=0·047) in enterovirus-D68-positive patients. Clinical outcomes at 30 days of follow-up were poor, with persistent neurological defi cits in all of 22 patients for whom data were available and no or minimal improvement in fl accid paralysis in 17 patients (77%).
12 (48%) of 25 nasopharyngeal or oropharyngeal samples from patients with acute fl accid myelitis were positive for enterovirus D68 by screening and confi rmatory sequencing with two independent RT-PCR assays. Among the 11 patients comprising two clusters in California and Colorado, seven (64%) tested positive for enterovirus D68 (fi gure 1). Of the patients with acute fl accid myelitis, none of 25 assessed by clinical assays and none of 19 assessed by enterovirus D68 5ʹ-UTR heminested RT-PCR tested positive for enterovirus from CSF (table 2) . 15 However, enterovirus D68 was detected in whole blood, stool, and nasopharyngeal and oro pharyngeal samples from a 6-yearold child (US/CA/14-6070) in the CHLA acute fl accid myelitis cluster. This was the only patient in whom enterovirus D68 was detected in whole blood or stool, and viral titres were lower than in nasopharyngeal and oropharyngeal samples (appendix A). Enterovirus D68 viraemia was identifi ed more than 1 week after URI onset during the child's hospital stay for progressive paralysis.
To search more broadly for potential neuroinvasive infections from enterovirus D68, we also analysed enterovirus-positive CSF from 16 consecutive paediatric patients from CHLA who presented with aseptic meningitis or encephalitis in August, 2014 (fi gure 1). These patients were part of the same paediatric population from which the three patients with acute (Enterovirus-positive CSF tested specifically for enterovirus D68) fl accid paralysis in the CHLA outbreak were derived. None of the CSF samples were positive for enterovirus D68 by VP1 heminested RT-PCR screening followed by confi rmatory sequencing (table 2) . To further characterise enterovirus D68 strains associated with patients with acute fl accid myelitis or non-acute fl accid myelitis (defi ned as URI or encephalitis without acute fl accid myelitis), we recovered 17 new full-length enterovirus D68 VP1 sequences and eight full-length or near-full-length genomes. Because of low concentrations of enterovirus D68 in several naso pharyngeal and oropharyngeal samples (appendix A), a com bination of metagenomic NGS, probe-based entero virus D68 target enrichment, and PCR with Sanger sequencing was needed for genome sequence recovery (appendix A). Alignment and phylogenetic analysis of the new VP1 sequences in comparison to all published VP1 sequences from 1962 to 2014 confi rmed that the original 1962 Fermon strain had diverged into three distinct clades (fi gure 2), as previously reported. 21 All 11 of the acute-fl accid-myelitis-associated enterovirus D68 viruses belonged to an evolutionarily recent cluster from 2012-14 (clade B1), which also included 17 VP1 sequences from non-acute fl accid myelitis 2014 respiratory outbreak isolates. 8, 22, 23 A 2011 enterovirus D68 isolate from a patient with non-acute fl accid myelitis encephalitis (US/CA/11-1767) was positioned just outside clade B1, whereas two strains from patients with non-acute fl accid myelitis URI (US/CA/09-871 and US/CA/10-786) were phylogenetically distant. The two initial patients with enterovirus-D68-positive acute fl accid myelitis, reported to the CDPH in January, 2012 (US/CA/12-5641, with hospital admission beginning in December, 2011), and November, 2012 (US/CA/12-5837), 5 were positioned near the root of clade B1, which is consistent with the emergence of this clade about 4·5 years ago by molecular clock analysis (appendix A). 
Glucose (normal 0·50-0·80 g/L) 0·58 (0·20, 0·28-1·24) 0·57 (0·7, 0·47-0·68) 0·58 (0·27, 0·28-1·24) 0·88 Phylogenetic analysis of all 17 enterovirus D68 genomes available as of Dec 1, 2014 (nine genomes from GenBank and eight newly sequenced enterovirus D68 genomes), recapitulated the same phylogenetic relationships noted in the VP1 tree, and all acute fl accid myelitis-associated enterovirus D68 genomes belonged to clade B1 (fi gure 3). Clade B1 genomes were 87% identical to the ancestral 1962 Fermon strain, 87-97% identical to other enterovirus D68 strains outside of clade B1, and 97-100% identical to each other by pairwise alignment, with no evidence of recombination (fi gure 3).
The 5ʹ-UTR internal ribosome entry site of enteroviruses has been associated with neurovirulence. 24 The sole nucleotide diff erence in the 5ʹ-UTR of the clade B1 strain was U339 compared with C339 in other enterovirus D68 strains. Among the three 5ʹ-UTR nucleotides associated with neurovirulence in enterovirus 71 (U448, A/U700, and G272), 24 only G272 was present in enterovirus D68, and this nucleotide was common to all sequenced enterovirus D68 genomes, regardless of clade. However, analysis of the entero virus D68 polyprotein revealed fi ve coding single nucleotide polymorphisms specifi c to clade B1 (fi gure 3). An additional coding polymorphism G1108 (fi gure 3), also noted in strains positioned just outside of clade B1, was situated at the 2B-2C proteolytic junction. Five of the six coding single nucleotide polymorphisms matched with poliovirus or enterovirus D70, or both.
One patient with acute fl accid myelitis in the present study (US/CA/14-6100) developed acute fl accid myelitis after a URI prodrome, whereas her sibling (US/CA/14-6100SIB) only exhibited URI symptoms (fi gure 1; table 2). Nasopharyngeal and oropharyngeal samples from the two children, both collected 9 days after onset of URI symptoms, were positive for enterovirus D68. Full genome sequencing of enterovirus D68 strains from the two siblings revealed no nucleotide diff erences. Despite being infected with a clade B1 enterovirus D68 strain (table 2), neither the unaff ected sibling nor two additional patients with URI developed acute fl accid myelitis within 60 days of follow-up.
To search for other pathogens that might be associated with acute fl accid myelitis, we did metagenomic NGS of 15 CSF samples, including 14 from patients with acute fl accid myelitis (six enterovirus D68 positive and eight enterovirus D68 negative) and one from a patient with non-acute fl accid myelitis enterovirus A71 encephalitis as a positive control (appendix B). 14 of 25 acute fl accid myelitis CSF samples were analysed because of limited sample availability and to maximise the depth of sequencing achieved. Between 13 million and 117 million sequence reads were generated per CSF sample (appendix B). No sequence reads corresponding to putative neuropathogenic viruses, bacteria, fungi, or parasites were recovered from CSF samples collected from patients with acute fl accid myelitis (appendices A and B). By contrast, the positive control CSF sample revealed 4600 of about 39 million sequenced reads aligned to enterovirus A71, with recovery of 92% of the genome (appendices A and B).
To aid in the recovery of enterovirus D68 genome sequences and detect potential co-infections from other viruses, we also did metagenomic NGS on 13 nasopharyngeal and oropharyngeal samples (two enterovirus-D68-positive acute fl accid myelitis, nine entero virus-D68-negative acute fl accid myelitis, one entero virus-D68-positive non-acute fl accid myelitis encephalitis, and one enterovirus-D68-positive URI), with 32-402 million reads generated per sample. Metagenomic NGS of nasopharyngeal and oropharyngeal samples from the two enterovirus-D68-positive acute fl accid myelitis cases-US/CA/12-5641 and US/CA/12-5837-revealed 1702 of 381 million and 2790 of 402 million reads corresponding to enterovirus D68 (appendices A and B), in table) . ||||Common viral laboratory contaminant of fetal bovine serum. Table 2 : Microbiological testing of patients with acute fl accid myelitis and patients with encephalitis or upper respiratory illness who were positive for enterovirus D68 Figure 2 : Phylogeny of enterovirus D68 by VP1 gene sequence All 180 complete enterovirus D68 VP1 sequences available in GenBank as of Dec 1, 2014 , including the 17 new enterovirus D68 VP1 gene sequences identifi ed in this study (in bold), were aligned using MUSCLE, 19 and phylogenetic trees were constructed using the MrBayes algorithm. 20 Enterovirus D68 strains from patients with acute fl accid myelitis were grouped together in a novel clade (clade B1) and included sequences from patients with severe respiratory illness from the 2014 outbreak. Patients with acute fl accid myelitis are in red, encephalitis in dark red, and respiratory illness only in blue. Branch lengths are drawn proportionally to the number of nucleotide substitutions per position, and support values are shown for each node. consistent with the low calculated enterovirus D68 titres of 53 575 copies per mL and 11 141 copies per mL, respectively (appendix B). A virus other than entero virus D68 was identifi ed from four of nine patients with enterovirus-D68-negative acute fl accid myelitis by meta genomic sequencing, including human adenovirus C (one read), human metapneumovirus (554 reads), a coinfection with human rhinovirus A24 (HRVA24; about 18 million reads) and human bocavirus (eight reads), and HRVA65 (157 000 reads; table 2; appendices A and B). By RT-PCR testing for enteroviruses 15 and confi rmatory Sanger sequencing of all 13 patients with enterovirus-D68-negative acute fl accid myelitis (table 2), three additional viruses-HRVA, HRVB, and enterovirus B-were detected. Nasopharyngeal and oropharyngeal swabs from seven (54%) of 13 patients with enterovirus-D68-negative acute fl accid myelitis harboured a virus diff erent from enterovirus D68.
Discussion
In this study, we detected enterovirus D68 in respiratory samples in over a third of patients with sporadic acute fl accid myelitis and two-thirds of those with acute fl accid myelitis from two temporally linked clusters, coincident with the widespread 2014 respiratory outbreak across the USA. The two clusters were also geographically linked to patients within the regions covered by CHCO and CHLA hospitals. By phylogenetic analysis, enterovirus D68 strains associated with acute fl accid myelitis grouped into a distinct clade B1 that emerged 4·5 years ago, as did most of the respiratory outbreak strains from 2014 sequenced so far. The two initial patients with enterovirus-D68-positive acute fl accid myelitis, reported from California in 2012, 5 were situated near the root of the clade. Coding polymorphisms associated with the clade B1 enterovirus D68 polyprotein shared homology with poliovirus and enterovirus D70. Enterovirus D68 viraemia was also detected for the fi rst time in a child with acute fl accid myelitis.
Our data strengthen the putative association between enterovirus D68 respiratory infection and acute fl accid myelitis and suggest that detection of enterovirus D68 in respiratory secretions from patients with acute fl accid myelitis is unlikely to be incidental. The timing of the enterovirus-D68-associated outbreak of severe respiratory illness across the USA in 2014 8, 22, 23 coincided with an apparent increased incidence of acute fl accid myelitis. 2, 5, 7 More than 80% of patients with acute fl accid myelitis reported fever or a viral URI prodrome, or both, which is consistent with antecedent enterovirus D68 respiratory infection. Enterovirus D68 was also the most common virus detected in nasopharyngeal and oropharyngeal samples from patients with acute fl accid myelitis, and none of the neurotropic enteroviruses typically associated with acute fl accid myelitis (enterovirus 70, enterovirus 71, and poliovirus) were detected. Other respiratory viruses found in nasopharyngeal and oropharyngeal samples from patients with acute fl accid myelitis-including four strains of rhinovirus, entero virus B, bocavirus, and metapneumovirus, and coxsackievirus A16 and enterovirus B in the stool of two patients with enterovirus-D68-positive acute fl accid myelitis-were detected only as individual cases. Finally, deep metagenomic sequencing of CSF samples from 14 patients with acute fl accid myelitis did not reveal evidence of an alternative infectious cause. Taken together, these fi ndings suggest that enterovirus D68 can be considered the most likely causative candidate for acute fl accid myelitis.
The anterior horn grey matter involvement noted in patients with acute fl accid myelitis is consistent with spinal motor neuron injury from direct viral invasion of tissue, which is characteristic of poliovirus and enterovirus A71 infections. 25, 26 We speculate that the coding polymorphisms noted in the clade B1 polyprotein might have conferred on enterovirus D68 an increased propensity for neurovirulence. The N860 polymorphism in the VP1 protein and the G1108 polymorphism at the proteolytic 2B/2C junction are particularly intriguing because the VP1 capsid change is specifi c to clade B1 enterovirus D68 and protease profi ling of enterovirus 3C proteins has shown enhanced cleavage of Q/G compared with Q/S peptides. 27 However, because the functional consequences of these polymorphisms are unknown, further investigation is needed to identify their clinical relevance, if any, with regard to acute fl accid myelitis.
So far, infections by clade B1 viruses have been reported in several patients with respiratory illness but without acute fl accid myelitis or other neurological disease. 8, 22, 23 Additionally, we identifi ed a sibling pair infected with identical clade B1 strains: one with a URI prodrome progressing to acute fl accid myelitis and the other with a self-limited URI. These two fi ndings suggest that the potential clinical manifestations and severity of enterovirus D68 infection are broad, and that hostspecifi c-perhaps immunological-or environmental factors might have a role in diff erential responses to infection.
Collection of clinical samples usually occurred more than 7 days after URI onset, which probably reduced overall titres and yield of enterovirus D68. Entero virus D68 titres in the respiratory tract of several patients with acute fl accid myelitis were low, in some cases needing two rounds of RT-PCR for detection (appendix B). Patients with acute fl accid myelitis who tested negative for enterovirus D68 had nasopharyngeal and oropharyngeal samples collected on average about 7 days later relative to URI onset than those who were positive for enterovirus D68 acute fl accid myelitis (p=0·012). The comparable clinical fi ndings between patients positive and negative for enterovirus D68 also suggest that the identifi cation of enterovirus D68 in only a subset of nasopharyngeal and oropharyngeal staff at CHLA, CHCO, the Viral and Rickettsial Disease Laboratory of the CDPH, and the US Centers for Disease Control and Prevention for undertaking diagnostic testing. We also thank the clinicians who referred cases to the California Encephalitis Project.
samples might be because of insuffi cient detection sensitivity caused by delayed sample collection.
The inability to detect enterovirus D68 in CSF is not surprising since reported rates of CSF detection for known neurotropic enteroviruses such as polioviruses and enterovirus A71 are as low as 0-5%. 25, 28, 29 Brain or spinal cord tissue from aff ected patients, which can assist in the diagnosis of viral encephalitis for which parallel CSF testing is negative, 10 was not available for testing. Another possible reason for the inability to detect enterovirus D68 in CSF is that the pathogenesis of acute fl accid myelitis is related to an aberrant immune response to recent enterovirus D68 infection and is not caused by direct neuroinvasion by the virus.
Two published cases suggest that enterovirus D68 is probably neurotropic. Enterovirus D68 was detected in the CSF of a young adult with acute fl accid paralysis in 2005, 4 and in the CSF and brain at autopsy in a 5-year-old boy with fulminant encephalitis in 2008. 3 The emergence in 2014 of rare cases of acute fl accid myelitis occurring concomitantly with a widespread entero virus D68 respiratory outbreak in the USA 2,5,7 and worldwide 6 is reminiscent of the large-scale outbreaks of acute haemor rhagic conjunctivitis accompanied by acute fl accid paralysis in about one in 10 000 patients from enterovirus D70 during the 1970s 30 and, more recently, sporadic outbreaks of enterovirus-A71-associated acute fl accid paralysis throughout the Asia-Pacifi c region from the 1990s to the present. 25 We detected entero virus D68 in whole blood, naso pharyngeal and oropharyngeal swab, and stool samples from a 6-year-old child in California with acute fl accid myelitis more than 1 week after URI onset and during the progressive period of his paralytic illness. Prolonged viraemia with enterovirus D68 might directly facilitate the development of neuroinvasive disease, akin to that noted in poliomyelitis. 26 Since all patients with acute fl accid myelitis in the present study continue to have residual limb weakness or other neurological defi cits, further investigation of the neuro pathogenic potential of enterovirus D68, especially clade B1 strains, is needed.
